Insider Transactions Reported by 23 Insiders of REGENERON PHARMACEUTICALS, INC.

Symbol
REGN on Nasdaq
Location
Tarrytown, NY

Insiders trading volume in the past year

REGENERON PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
GEORGE YANCOPOULOS Bd. Co-Chair, President & CSO, Director $804,491,660 31 Dec 2025
LEONARD S. SCHLEIFER Bd. Co-Chair, President & CEO, Director $493,538,603 31 Dec 2025
VAGELOS P ROY Director $444,337,350 03 Apr 2023
Neil E. Stahl EVP Research and Development $43,324,609 16 Dec 2024
ANDREW J. MURPHY EVP Research $36,595,908 09 Dec 2025
JOSEPH J. LAROSA EVP General Counsel and Secret $29,938,330 05 Dec 2025
George L. Sing Director $25,592,887 02 Jan 2026
Daniel P. Van Plew EVP & General Mgr, Industrial $24,589,665 09 Dec 2025
Robert E. Landry EVP Finance CFO $22,918,280 02 Feb 2024
Christopher R. Fenimore EVP Finance CFO $15,475,790 05 Dec 2025
Arthur F. Ryan Director $13,972,623 -$156,402 -1.1% 02 Mar 2026
Marion McCourt EVP Commercial $10,202,879 09 Dec 2025
Michael S. Brown Director $9,930,105 02 Jan 2026
Joseph L. Goldstein Director $5,173,843 02 Jan 2026
Christine A. Poon Director $4,028,389 -$4,252,745 -51% 02 Jan 2026
Jason Pitofsky SVP Controller $3,516,873 -$1,865,824 -35% 09 Feb 2026
Marc Tessier-Lavigne Director $2,315,367 03 Jan 2023
Bonnie L. Bassler Director $1,362,400 -$1,770,000 -57% 07 Jan 2026
Huda Y. Zoghbi Director $1,345,370 -$1,279,812 -49% 19 Feb 2026
N. ANTHONY COLES Director $1,322,985 02 Jan 2026
Craig B. Thompson Director $598,199 02 Jan 2026
Kathryn Guarini Director $465,437 02 Jan 2026
David P. Schenkein Director $465,437 02 Jan 2026

Recent Insider Transactions by Companies or Individuals for REGENERON PHARMACEUTICALS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.